Graft-versus-host disease (supportive care)
Also known as: Graft-versus-host disease, GVHD, Acute GVHD, Chronic GVHD, Post-allogeneic transplant GVHD
Graft-versus-host disease (GVHD) is a complication of allogeneic haematopoietic stem cell transplantation wherein donor-derived immunocompetent T-lymphocytes initiate an immune response against recipient tissues. Acute GVHD primary involves the integumentary system, liver, and gastrointestinal tract; chronic GVHD may manifest as multi-organ dysfunction and systemic fibrosis. Clinical management is strictly overseen by specialist transplant units utilising immunosuppressive therapy and rigorous monitoring for opportunistic infections. Traditional Chinese Medicine (TCM) serves solely as a framework for addressing stable, protracted symptoms and must never substitute for primary oncological or immunological management. Cited evidence [1,3] pertains to transplant protocols and gastrointestinal pathology; it does not evaluate the efficacy or safety of acupuncture or Chinese herbal medicine in this context. Any supportive TCM interventions require explicit authorisation from the transplant team due to significant risks of infection, haemorrhage, and pharmacological interactions.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Maintain a daily clinical log documenting body temperature, weight, fluid balance, and any changes to the integument, oral mucosa, or bowel motility for specialist review.
- •Adhere strictly to the transplant service's food-safety protocols, infection-control measures, and vaccination schedule; avoid unapproved supplements, botanicals, and live microbial products.
- •Utilise only hospital-sanctioned products for dermatological and oral hygiene, ensuring fragile tissues are protected from ultraviolet radiation and mechanical friction.
- •Implement a structured balance of rest with individually paced physical activity, seeking physiotherapy or occupational therapy input for stiffness or loss of function.
Cautions & Contraindications
- •Never replace, reduce or delay prescribed immunosuppression, GVHD prophylaxis or specialist treatment because of a TCM assessment. The supplied studies address specialist transplant management, not complementary-treatment substitution.[,,]
- •Defer elective needling during suspected infection, unstable GVHD, active bleeding or clinically important cytopenias until the transplant team approves. Review current blood counts and local oncology policy rather than applying an unsupported universal threshold. This is a conservative clinical precaution; the supplied records do not establish acupuncture safety thresholds.[,]
- •Do not initiate herbal formulas without transplant-prescriber and pharmacist review of immunosuppressants, anti-infectives, anticoagulants, organ function and product quality. The supplied records contain no herbal interaction or safety studies; this precaution reflects the high-risk treatment context, not demonstrated compatibility.[,]
- •Do not offer acupuncture or herbs as fertility preservation on the basis of the supplied photopheresis study: its fertility findings are from mice and concern a different intervention. Refer fertility concerns to the transplant and reproductive-medicine teams.[]
When to reassess or seek care again
Obtain transplant-team clearance before any intervention and review symptoms and safety at every contact. For an agreed supportive trial in stable disease, review within 1–2 weeks using a 0–10 target-symptom score, oral intake, stool frequency where relevant, and a functional measure such as walking tolerance or joint range. Stop and contact the team immediately for new organ symptoms, infection concerns, bleeding or deterioration. If there is no meaningful improvement after 2–4 weeks, discontinue or revise supportive care with the treating team; never defer scheduled GVHD assessments.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Haematologica · 2026
- Transplantation proceedings · 2026
- Frontiers in immunology · 2026
- International immunopharmacology · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
